Overview |
bs-8331R-APC-Cy5.5 |
CPXCR1 Polyclonal Antibody, APC-Cy5.5 Conjugated |
WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
Human, Horse |
Specifications |
APC-Cy5.5 |
Rabbit |
KLH conjugated synthetic peptide derived from human CPXCR1 |
151-250/301 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
53336 |
Cytoplasm, Nucleus, Secreted, Extracellular matrix |
Cancer/testis antigen 77; CPX chromosome region, candidate 1; CPX candidate region 1 protein; CPX chromosomal region candidate gene 1 protein; CPX chromosomal region candidate gene 1 protein homolog; CPX chromosome region, candidate 1; CT77; Gm1143; CPXCR_HUMAN. |
CPXCR1 is widely expressed in fetal tissues, including the tongue, mandible and palate with an unknown function. Cleft palate most commonly occurs as a sporadic multifactorial disorder with a clear but difficult to define genetic component. As a semi-dominant disorder, X-linked cleft palate (CPX) provides a useful model to investigate a congenital defect that is little influenced by non-genetic factors. |
Application Dilution |
WB |
1:300-5000 |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |